{"schema_version":"secwatch.filing_event.v1","accession":"0001378325-25-000008","form_type":"8-K","ticker":"CV","cik":"0001378325","company_name":"CapsoVision, Inc","filed_at":"2025-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.848530+00:00","generated_at":"2026-05-17T12:58:20.067922+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"CapsoVision Q2 revenue $3.3M (+17% YoY); IPO closes raising $23.4M","bullets":["Revenue $3.3M, up 17% YoY, driven by higher CapsoCam Plus capsule sales.","Gross profit $1.8M (55% margin) vs. $1.6M (56%) in Q2 2024.","Operating expenses $6.5M, down $0.4M from prior year due to reduced clinical trial costs.","Closed IPO on July 3, 2025, net proceeds of $23.4M; cash was $1.1M at June 30.","Filed 510(k) for CapsoCam Colon in June 2025; AI module addition targeted for FDA approval."],"urls":{"canonical":"https://secwatch.observer/filing/0001378325-25-000008","json":"https://secwatch.observer/filing/0001378325-25-000008.json","markdown":"https://secwatch.observer/filing/0001378325-25-000008.md","text":"https://secwatch.observer/filing/0001378325-25-000008.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1378325/000137832525000008/0001378325-25-000008-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1378325/000137832525000008/cv-20250814.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T12:58:20.067922+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}